Related Experiment Video
Updated: Jan 26, 2026

siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells
Published on: May 24, 2014
Ubiquitin binds the amyloid β peptide and interferes with its clearance pathways
F Bellia1, V Lanza1, S García-Viñuales1
1Consiglio Nazionale delle Ricerche , Istituto di Biostrutture e Bioimmagini , Via P. Gaifami 18 , 95126 Catania , Italy .
Alzheimer's disease involves impaired protein clearance. This study shows amyloid-beta binds ubiquitin, affecting its aggregation and degradation, potentially impacting proteostasis in Alzheimer's disease.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Alzheimer's Disease (AD) is linked to impaired proteostasis and reduced Ubiquitin Proteasome System (UPS) activity.
- Amyloid-beta (Aβ) peptides are implicated in AD pathogenesis, and ubiquitin (Ub) is found in amyloid plaques.
Purpose of the Study:
- To investigate whether ubiquitin (Ub) binds to amyloid-beta (Aβ) peptides.
- To determine the effect of Ub binding on Aβ clearance pathways and aggregation.
Main Methods:
- Utilized MALDI-TOF/UPLC-HRMS, fluorescence, NMR, SPR, Microscale Thermophoresis (MST), and molecular dynamics.
- Performed ELISA assays in neuroblastoma cell lysates.
- Investigated the impact on Insulin Degrading Enzyme (IDE) degradation and Ub chain growth.
Main Results:
- Demonstrated Aβ40 binds Ub with 1:1 stoichiometry and a high micromolar dissociation constant (Kd).
- Identified specific interaction sites between Aβ N-terminus and Ub C-terminus, inducing structural changes in Aβ.
- Showed Ub-bound Aβ aggregates less, degrades slower via IDE, and Aβ1-16 inhibits Ub chain formation.
Conclusions:
- The non-covalent interaction between Aβ and Ub influences upstream UPS events.
- This interaction may play a role in the proteome maintenance malfunction observed in Alzheimer's Disease.
- Suggests potential therapeutic targets related to Aβ-Ub interactions in AD.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Interference and Diffraction
Peptide Bonds

